BIOAESTHETICS CORP

Profile

Company Names

BIOAESTHETICS CORP

Addresses

6 DAVIS DRIVE, SUITE 828, RESEARCH TRIANGLE PARK, NC 27709

6 DAVIS DRIVE, SUITE 828, RESEARCH TRIANGLE PARK, NC 27709

1441 CANAL STREET, SUITE 407-A, NEW ORLEANS, LA 70112

Phone Numbers

833-622-4723
504-508-8337

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$6,899,815.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-09-09 
$6,399,815.00 
$6,399,815.00 
$0.00 
Equity 
1
2017-09-08 
$500,000.00 
$1,250,000.00 
$750,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SANDRA 
 
COUFAL 
DIRECTOR
MINIVAX, INC.   |  TRICIDA, INC.   |  SAFETY SPOT INC.   |  BIOAESTHETICS CORP
SANDRA 
I. 
COUFAL 
DIRECTOR
SIBLING CAPITAL FUND II-A L.P.   |  SIBLING CAPITAL FUND II-B L.P.   |  SIBLING CAPITAL FUND II-C L.P.   |  BIOAESTHETICS CORP
YI 
 
GU 
DIRECTOR
HEMI VENTURES FUND I, L.P.   |  BIOAESTHETICS CORP
WILLIAM 
 
HEIM 
EXECUTIVE OFFICER, DIRECTOR
BIOAESTHETICS CORP
WILLIAM 
M. 
HEIM 
EXECUTIVE OFFICER, DIRECTOR
BIOAESTHETICS CORP
NICHOLAS 
 
PASHOS 
EXECUTIVE OFFICER, DIRECTOR
BIOAESTHETICS CORP
NICHOLAS 
C. 
PASHOS 
EXECUTIVE OFFICER, DIRECTOR
BIOAESTHETICS CORP
M. 
SUE 
PRESTON 
DIRECTOR
BIOAESTHETICS CORP
MARTHA 
SUE 
PRESTON 
DIRECTOR
MINIVAX, INC.   |  BIOAESTHETICS CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-01-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
2020-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
2017-10-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-09-08 
2017-09-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-09-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#